News

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...
The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...
The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.
The agreement has been designed to offer a turnkey service to companies seeking faster time to market.
Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without ...
NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...
The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.
The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry ...
NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with TGCTs that require systemic ...
The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound ...
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...